Pain Management Market Drives by Increase in Chronic Pain Conditions, Improving Reimbursement Landscape and Global Industry Outlook 2023

Global Pain Management Market is expected to register a CAGR of 6.0% during the forecast period of 2018–2023

The "Pain Management Market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the pain management market is expected to register a CAGR of 6.0% during the forecast period of 2018–2023".

Pain Management Market

Pain is considered as a clinical, social, and economic burden in communities around the world, as chronic pain is associated with various health conditions. The increasing prevalence of pain pushes the demand for better diagnosis and treatments.

Various other factors such as increasing geriatric population, improved reimbursement policies in developed countries, the increasing prevalence of cancer pain, improving regulatory framework, growing research funding, unmet medical needs, rising competition among market players, and increasing government assistance are continuously contributing to the growth of the global pain management market.

Free Sample at https://www.marketresearchfuture.com/sample_request/5975

According to a study published in the Current Pain and Headache Reports Journal in 2016, it was found that Peripheral Nerve Stimulation (PNS) is a widely accepted treatment procedure for chronic pain. The StimRouter neuromodulation system by Bioness, Inc is a PNS technology-based device specifically designed to treat chronic pain. The device received the FDA approval in 2015.

Competitive Landscape

top distinguished players in the global pain management market are, Abbott Laboratories, Abbvie, Allergan, Astellas Pharma, AstraZeneca plc, Bayer AG, Codman And Shurtleff Inc, DJO Global LLC, Eli Lilly & Company, Endo Health Solutions, F. Hoffmann-La Roche Ltd, Forest Laboratories, GlaxoSmithKline plc, Johnson & Johnson Services Inc., Mallinckrodt plc, Medtronic PLC, ST. Jude Medical Inc., Boston Scientific Corporation, Pfizer Inc., Halyard Health Inc., Smiths Medical, B. Braun Melsungen AG, Neurotech Na Inc., Becton, Dickinson and Company, Nevro Corp., Merck & Co. Inc., Novartis AG, Purdue Pharma LP, Sanofi, Stryker Corporation, Teva Pharmaceuticals, and others.

Intended Audience

Pharmaceutical Companies

Medical Devices Companies

Research and Development (R&D) Companies

Government Research Institutes

Academic Institutes and Universities

Improving reimbursement landscape is favoring the growth of the Pain Management Market. Furthermore, the governments in various countries have endeavored to set up pain rehabilitation centers which help to boost the growth of the market.

Industry Updates

April 2019 - Avanos Medical, Inc., a medical technology company, announced that it has received US Food and Drug Administration (FDA) 501(k) clearance for its postoperative pain management device, ON-Q Bolus.

Segmentation

The global pain management market is segmented on the basis of type of pain management devices, type of pain management drugs, indication, mode of purchase, and end-user.

On the basis of type of pain management devices, the market is classified as neurostimulation devices, analgesic infusion pumps, and ablation devices. The neurostimulation devices are further segmented into Transcutaneous Electrical Nerve Stimulation (TENS) devices and Spinal Cord Stimulation (SCS) devices. Ablation devices are further segmented into RF ablation devices and cryoablation devices.

On the basis of type of pain management drugs, the market is classified as Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), anticonvulsants, anesthetics, opioids, antimigraine agents, antidepressants, and others. The opioids segment is further classified as oxycodones, hydrocodone, tramadol, morphine, codeine, fentanyl, meperidine, methadone, and others.

On the basis of indication, the market is classified as neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, fibromyalgia, chronic back pain, arthritic pain, migraine, post-operative pain, and others.

On the basis of the mode of purchase, the market is classified as over the counter and prescription-based.

On the basis of end-user, the market is classified as hospitals and clinics, pharmaceutical companies, medical device companies, research and academic institutes, and others.

Get an Amazing Discount at https://www.marketresearchfuture.com/check-discount/5975

Regional Analysis

The Americas dominates the pain management market owing to the increasing prevalence of chronic pain, well-developed technology, high healthcare expenditure, and the presence of leading players. According to a study published in the Drug and Alcohol Dependence Journal in 2017, more than 100 million adult Americans have chronic pain. Chronic low back pain and headaches are the most commonly diagnosed conditions. It is also stated that these conditions are more prevalent in women than men, i.e., 34.3% in women and 26.7% in men in the United States.

Europe holds the second position in the pain management market. It is expected that the increasing contribution towards research and development and increasing competition among marketers are likely to drive the European pain management market.

Asia Pacific is the fastest growing pain management market owing to a huge patient pool, increasing demand for treatments, and increasing healthcare expenditure. As per the data suggested by the Australian Institute of Health and Welfare during 2015 to 2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014 to 2015.

The Middle East and Africa holds the lowest share of the global pain management market due to low development, lack of technical knowledge, and poor medical facilities.

Browse Complete Premium Research Report at https://www.marketresearchfuture.com/reports/pain-management-market-5975

LIST OF TABLES

Table 1 Pain Management Industry Synopsis, 2018–2023

Table 2 Pain Management Market Estimates & Forecast, 2018–2023, (USD Million)

Table 3 Pain Management Market, By Region, 2018–2023, (USD Million)

Table 4 Pain Management Market, By Type Of Pain Management Devices, 2018–2023, (USD Million)

Table 5 Pain Management Market, By Type Of Pain Management Drugs, 2018–2023, (USD Million)

Table 6 Pain Management Market, By Indication, 2018–2023, (USD Million)

Table 7 Pain Management Market, By Mode Of Purchase, 2018–2023, (USD Million)

Table 8 Pain Management Market, By End-User, 2018–2023, (USD Million)

Table 9 North America Pain Management Market, By Type Of Pain Management Devices, 2018–2023, (USD Million)

Table 10 North America Pain Management Market, By Type Of Pain Management Drugs, 2018–2023, (USD Million)

..continued.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Mr. Akash Anand.
Email: Send Email
Organization: Market Research Future
Address: Magarpatta Road, Hadapsar, Pune.
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/pain-management-market-5975

Release ID: 505896